Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Autologous cultured chondrocytes - Co.don AG

Drug Profile

Autologous cultured chondrocytes - Co.don AG

Alternative Names: ADCT; Chondrotransplant DISC; Spherox

Latest Information Update: 19 Jun 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator co.don AG
  • Class Cell therapies
  • Mechanism of Action Chondrocytes-replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Back pain
  • Registered Knee injuries

Most Recent Events

  • 13 Jun 2018 Co.don AG enters into a term sheet with Haemo Pharma for the distribution of autologous cultured chondrocytes in Austria
  • 05 Apr 2018 Co.don AG completes the co.dis phase II trial in Knee injuries
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top